- Home
- ZBRA vs NBIX Comparison
ZBRA vs NBIX Comparison
Compare ZBRA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZBRA | NBIX |
|---|---|---|
| Founded | 1969 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.9B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ZBRA | NBIX |
|---|---|---|
| Price | $250.61 | $130.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 21 |
| Target Price | ★ $339.75 | $175.95 |
| AVG Volume (30 Days) | 782.9K | ★ 1.2M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | ★ 8.18 | 4.67 |
| Revenue | ★ $5,396,000,000.00 | $161,626,000.00 |
| Revenue This Year | $12.81 | $22.57 |
| Revenue Next Year | $5.57 | $9.56 |
| P/E Ratio | $30.91 | ★ $27.47 |
| Revenue Growth | 8.33 | ★ 977.51 |
| 52 Week Low | $205.79 | $84.23 |
| 52 Week High | $352.66 | $160.18 |
Technical Indicators
Market Signals| Indicator | ZBRA | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 42.87 |
| Support Level | $250.31 | $122.14 |
| Resistance Level | $303.40 | $129.94 |
| Average True Range (ATR) | 11.89 | 4.39 |
| MACD | 1.19 | -0.72 |
| Stochastic Oscillator | 27.20 | 39.90 |
Price Performance
Historical ComparisonAbout ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.